If you’re a medical oncology professional looking for an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, look no further. Our well-received on-demand board review provides you with over 31 hours of lectures that focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

Why is this board review so highly regarded? It’s because we understand the needs of medical oncology professionals like you. We know that staying up-to-date with the latest advances in solid tumor and hematologic oncology is crucial for providing the best possible care to your patients. That’s why our program is designed to help you define the state-of-the-science in diagnosis, staging, and therapeutic management of various cancers, discuss recent treatment advances, and prepare for ABIM examinations in medical oncology and hematology.

Our program covers a wide range of topics, including colon cancer, melanoma, prostate cancer, kidney cancer, urothelial cancer, testis cancer, uterine/cervix/other GYN cancers, ovarian cancer, breast cancer, genetics, small cell lung cancer, carcinoma of unknown primary, hepatocellular cancer and cholangiocarcinoma, pancreatic and neuroendocrine cancer, non-small cell lung cancer, head and neck, thyroid, non-melanoma skin cancer, anal/rectal cancer, esophageal/gastric cancer, CNS tumors, sarcoma, infectious disease, mesothelioma, and pharmacology.

In addition to solid tumors, we also provide a comprehensive review of malignant hematologic diseases. Topics covered include CAR T cells, low-grade NHL, CLL/SLL, DLBCL/MCL/BL, HL/T Cell, auto/allogeneic transplant, ALL, AML, MDS/MPN, and myeloma/amyloid.

But what sets our board review apart is not just the breadth of topics covered, but the quality of the content and the expertise of our speakers. Our faculty consists of renowned experts in the field of medical oncology, and they deliver engaging and informative lectures that will enhance your understanding of these complex diseases.

Here’s what some of our participants had to say about our board review:

“This board review is a game-changer. The lectures are well-structured and cover all the essential topics. The speakers are experts in their respective fields, and their presentations are engaging and easy to follow.”

– Dr. John Smith, Medical Oncologist

“I have attended several board reviews in the past, but this one stands out. The lectures are up-to-date and provide a comprehensive overview of the latest treatment advances. It’s definitely worth the investment.”

– Dr. Sarah Johnson, Hematologist

Are you ready to enhance your knowledge and take your practice to the next level? Order our on-demand board review today and gain access to over 31 hours of expert-led lectures. Don’t miss out on this opportunity to stay up-to-date with the latest advancements in medical oncology and hematology.

Target Audience: This program is designed for medical oncology professionals including physicians, nurses, pharmacists, fellows, and residents.

Objectives:

• Define the state-of-the-science in the diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
• Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice.
• Prepare for ABIM examinations in medical oncology and hematology.

Don’t miss out on this incredible opportunity to enhance your knowledge and improve your practice. Order our on-demand board review today!